Professional Advisory Board

Professional advisors to the Children’s Cause for Cancer Advocacy (CCCA) are among the nation’s most distinguished researchers in pediatric oncology. They offer keen insights pro bono to CCCA on issues of national importance in the research, care, treatment, and follow-up of children with cancer and long-term survivors.

Chairman

• David G. Poplack, MD Elise C. Young Professor of Pediatric Oncology Head, Hematology Oncology Section
  Department of Pediatrics, Baylor College of Medicine Director, Texas Children’s Cancer Center, Houston, TX

Members

• Robert J. Arceci, MD, PhD Director of Pediatric Oncology, Department of Pediatric Oncology
  Johns Hopkins Hospital, Baltimore, MD
• Archie Bleyer, MD Medical Advisor
  St. Charles Medical Center, Bend, OR
• Mark Bernstein, MD Chief of Hematology/Oncology Department
  Saint Justine Hospital, Montreal, Quebec, Canada
• Robert P. Castleberry, MD Professor of Pediatrics, Pediatric Hematology/Oncology
  University of Alabama at Birmingham, Birmingham, AL
• Henry Friedman, MD Co-Director of the Clinical Neuro-Oncology Program at the Brain Tumor Center
  Professor of Pediatrics
  Duke University Medical Center, Durham, NC
• Daniel M. Green, MD Staff Physician
  Department of Pediatrics
  Roswell Park Cancer Institute, Buffalo, NY
• Michael P. Link, MD Professor of Pediatrics
  Chief, Division of Pediatric Hematology/Oncology
  Stanford University School of Medicine, Stanford, CA
• Sharon Murphy, MD Director, Children’s Cancer Research Institute
  University of Texas Health Science Center, San Antonio, TX
• Gregory H. Reaman, MD Chairman
  Children’s Oncology Group, Bethesda, MD
• Charles A. Sklar, MD Associate Attending, Department of Pediatrics
  Director, Long Term Follow-Up Program
  Memorial Sloan-Kettering Cancer Center, New York, NY

Institutional affiliation noted for purposes of identification only.